Influence of psychotropic drugs and β-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice
Author:
- Nandkumar S. ShahNSNandkumar S. Shah
- 1 March 1976
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 25 (5) , 591-597
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- The Metabolism of Chlorpromazine by Developing Rabbit LiverCanadian Journal of Physiology and Pharmacology, 1971
- Depressant effect of Δ1-tetrahydrocannabinol enhanced by inhibition of its metabolismEuropean Journal of Pharmacology, 1970
- Tissue concentrations of p-hydroxynorephedrine in rats injected with d-amphetamine: Effect of pretreatment with desipramineLife Sciences, 1969
- Effects of amphetamine on urinary and tissue catecholamines in rats after inhibition of its metabolism with desmethylimipramineEuropean Journal of Pharmacology, 1968
- Potentiation and blockade of the central action of amphetamine by chlorpromazineBiochemical Pharmacology, 1968
- Studies on the uptake of radiolabeled DOPA, 5-HTP and tryptophan in rat tissuesin vivo: Effect of methionine, tryptophan and some keto acidsInternational Journal of Neuropharmacology, 1968
- Desipramine and amphetamine metabolismJournal of Pharmacy and Pharmacology, 1967
- On the mechanism of amphetamine potentiation by desipramine (DMI)Life Sciences, 1966
- Metabolic fate of mescaline in manPsychopharmacology, 1966
- A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counterAnalytical Biochemistry, 1960